Publications by authors named "Richard Stock"

Claim this Profile
N
Novel bioabsorbable, low-dose rate brachytherapy device (CivaSheet) with radical prostatectomy and adjuvant external beam radiation for the management of prostate cancer.
Kennedy E Okhawere, Shirin Razdan, Alp Tuna Beksac, Indu Saini, Laura Zuluaga, Richard G Stock

BJU Int· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PACE-B: Where does this position SBRT as an option for localized prostate cancer?
Juanita Crook, Pierre Blanchard, Jay Ciezki, Gregory Merrick, Jeremy Millar, Richard Stock

Radiother Oncol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Method to determine the nadir PSA following partial gland ablation.
Nelson N Stone, Vassilios Skouteris, Rendi Shu, Richard G Stock, Ben Gl Vanneste

BJUI Compass· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A unified strategy to focal brachytherapy incorporating transperineal biopsy, image fusion, and real-time implantation with and without rectal spacer simulated in prostate phantoms.
Ben G L Vanneste, Basile Skouteris, Luis Campos Pinheiro, Robert Voncken, Evert J Van Limbergen, Richard Stock

J Contemp Brachytherapy· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Concurrent Chemotherapy and Pelvic Radiation Therapy Compared With Pelvic Radiation Therapy Alone as Adjuvant Therapy After Radical Surgery in High-Risk Early-Stage Cancer of the Cervix.
William A Peters, P Y Liu, Rolland J Barrett, Richard J Stock, Bradley J Monk

J Clin Oncol· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical and treatment characteristics of secondary bladder malignancies following low dose rate brachytherapy for prostate cancer.
Chih Peng Chin, William H Smith, Jamie Cesaretti, Mitchell Terk, Evan B Garden, Richard G Stock

Urol Oncol· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes after PD-103 versus I-125 for low dose rate prostate brachytherapy monotherapy: An international, multi-institutional study.
Chad Tang, Jeremiah Sanders, Howard Thames, David M Swanson, Juanita M Crook, Richard Stock

Radiother Oncol· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sexual health and treatment-related sexual dysfunction in sexual and gender minorities with prostate cancer.
Daniel R Dickstein, Collin R Edwards, Eric J Lehrer, Elizabeth S Tarras, Matthew Gallitto, Richard Stock

Nat Rev Urol· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
External Beam Radiation Therapy With or Without Brachytherapy Boost in Men With Very-High-Risk Prostate Cancer: A Large Multicenter International Consortium Analysis.
Sagar A Patel, Ting Martin Ma, Jessica K Wong, Bradley J Stish, Robert T Dess, Richard G Stock

Int J Radiat Oncol Biol Phys· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of AUA and phoenix definitions of biochemical failure following permanent brachytherapy for prostate cancer.
Zeynep G Gul, Rollin Say, Vassilios M Skouteris, Richard G Stock, Nelson N Stone

Brachytherapy· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oligoprogression of Solid Tumors on Immune Checkpoint Inhibitors: The Impact of Local Ablative Radiation Therapy.
Kunal K Sindhu, Anthony D Nehlsen, Eric J Lehrer, Jared P Rowley, Richard G Stock

Biomedicines· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Factors associated with late local failure and its influence on survival in men undergoing prostate brachytherapy.
Nelson N Stone, Pamela D Unger, Rendi Sheu, Barry S Rosenstein, Richard G Stock

Brachytherapy· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radium-223 for Metastatic Castrate-Resistant Prostate Cancer.
Kunal K Sindhu, Anthony D Nehlsen, Richard G Stock

Pract Radiat Oncol· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Ocular complications with the use of radium-223: a case series.
Julie R Bloom, Alexandra G Castillejos, Brianna Jones, Nimesh Patel, Barry S Rosenstein, Richard G Stock

Radiat Oncol· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interplay Between Duration of Androgen Deprivation Therapy and External Beam Radiotherapy With or Without a Brachytherapy Boost for Optimal Treatment of High-risk Prostate Cancer: A Patient-Level Data Analysis of 3 Cohorts.
Amar U Kishan, Alison Steigler, James W Denham, Almudena Zapatero, Araceli Guerrero, Richard G Stock

JAMA Oncol· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of angiotensin converting enzyme inhibitors is associated with reduced risk of late bladder toxicity following radiotherapy for prostate cancer.
Sarah L Kerns, Ashley Amidon Morlang, Sharon M Lee, Derick R Peterson, Brian Marples, Richard G Stock

Radiother Oncol· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low dose rate brachytherapy for primary treatment of localized prostate cancer: A systemic review and executive summary of an evidence-based consensus statement.
Martin T King, Mira Keyes, Steven J Frank, Juanita M Crook, Wayne M Butler, Richard G Stock

Brachytherapy· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Performance of a Prostate-Specific Membrane Antigen Positron Emission Tomography/Computed Tomography-Derived Risk-Stratification Tool for High-risk and Very High-risk Prostate Cancer.
Michael Xiang, Ting Martin Ma, Ricky Savjani, Erqi L Pollom, R Jeffrey Karnes, Richard G Stock

JAMA Netw Open· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Live implant dosimetry may be an effective replacement for postimplant computed tomography in localized prostate cancer patients receiving low dose rate brachytherapy.
Davood Roshan, Kieran Joyce, Peter Woulfe, Pradeep Reddy Gorakati, Richard Stock

Brachytherapy· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patterns of Clinical Progression in Radiorecurrent High-risk Prostate Cancer.
Rebecca G Philipson, Tahmineh Romero, Jessica K Wong, Bradley J Stish, Robert T Dess, Richard G Stock

Eur Urol· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of Multimodal Therapies and Outcomes Among Patients With High-Risk Prostate Cancer With Adverse Clinicopathologic Features.
Amar U Kishan, R Jeffrey Karnes, Tahmineh Romero, Jessica K Wong, Giovanni Motterle, Richard G Stock

JAMA Netw Open· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of a method for generating SNP interaction-aware polygenic risk scores for radiotherapy toxicity.
Nicola Rares Franco, Michela Carlotta Massi, Francesca Ieva, Andrea Manzoni, Anna Maria Paganoni, Richard G Stock

Radiother Oncol· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radiopharmaceuticals for Bone Metastases.
Andrew W Smith, Benjamin A Greenberger, Robert B Den, Richard G Stock

Semin Radiat Oncol· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and tolerability of venom immunotherapy: Evaluation of 581 rush- and ultra-rush induction protocols (safety of rush and ultra-rush venom immunotherapy).
Richard Stock, Tatjana Fischer, Katharina Aẞmus, Nadja Zoeller, Hanns Ackermann

World Allergy Organ J· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis